Related Experiment Videos
ALS therapy: targets for the future
1Unit of Neurobiology, UCNRS 1485, Faculty of Medicine, Limoges, France.
Abstract:
There are four main hypotheses about the cause of ALS: excitotoxicity linked to glutamate receptor overactivation; mutation of the superoxide dismutase gene; production of autoantibodies to calcium channels; neurofilament accumulation. The motoneuron degeneration characteristic of ALS could be caused by any one or a combination of these mechanisms. Future therapeutic approaches should be based on these mechanisms and given in combination so that different levels of the degenerative process are targeted. Protection against excitotoxicity could be achieved with a combination of pharmacologic agents having neuroprotective activity, such as antiglutamate agents (e.g., riluzole), N-methyl-D-aspartate (NMDA) and non-NMDA antagonists, free-radical scavengers, calcium-channel blockers, and neurotrophic factors. Gene transfer is a possible future approach when causative mutations are identified. Transfer of genes encoding neuroprotective agents or genetically modified cells stably expressing these agents is another possible strategy.
Insights
Amyotrophic lateral sclerosis (ALS) may stem from excitotoxicity, gene mutations, autoantibodies, or neurofilament issues. Combined therapies targeting these mechanisms offer future treatment potential for motoneuron degeneration.
Area of Science:
- Neuroscience
- Genetics
- Immunology
Background:
- Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease characterized by motoneuron degeneration.
- Several hypotheses exist regarding the underlying causes of ALS, including excitotoxicity, genetic mutations, autoimmune responses, and protein accumulation.
Purpose of the Study:
- To review the primary hypotheses concerning the etiology of ALS.
- To explore potential therapeutic strategies based on these etiological mechanisms.
Main Methods:
- Literature review of current hypotheses on ALS pathogenesis.
- Analysis of potential therapeutic targets and combination strategies.
Main Results:
- Four main hypotheses for ALS causation are identified: glutamate receptor overactivation (excitotoxicity), superoxide dismutase gene mutations, autoantibodies against calcium channels, and neurofilament accumulation.
- Motoneuron degeneration in ALS may result from one or a combination of these factors.
Conclusions:
- Future ALS therapies should integrate approaches targeting multiple etiological mechanisms simultaneously.
- Potential treatments include neuroprotective agents (antiglutamates, NMDA/non-NMDA antagonists, free-radical scavengers, calcium-channel blockers, neurotrophic factors) and gene transfer strategies for identified mutations.